Acadia Investors Get Class Cert. In Suit Over Parkinson's Drug

By Bonnie Eslinger · March 11, 2024, 10:55 PM EDT

A California federal judge on Monday certified a class of Acadia Pharmaceuticals investors in a lawsuit accusing the company of making false and misleading statements regarding the likelihood that its Parkinson's...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

City of Birmingham Relief and Retirement System et al v. Acadia Pharmaceuticals Inc. et al

Case Number

3:21-cv-00762

Court

California Southern

Nature of Suit

Securities/Commodities

Date Filed

April 19, 2021